Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Common Equity (2016 - 2026)

Bio-Techne has reported Common Equity over the past 17 years, most recently at $2.0 billion for Q4 2025.

  • For Q4 2025, Common Equity fell 3.25% year-over-year to $2.0 billion; the TTM value through Dec 2025 reached $2.0 billion, down 3.25%, while the annual FY2025 figure was $1.9 billion, 7.25% down from the prior year.
  • Common Equity for Q4 2025 was $2.0 billion at Bio-Techne, up from $2.0 billion in the prior quarter.
  • Over five years, Common Equity peaked at $2.1 billion in Q3 2024 and troughed at $1.5 billion in Q1 2021.
  • A 5-year average of $1.9 billion and a median of $1.9 billion in 2023 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: increased 19.88% in 2021 and later fell 8.08% in 2025.
  • Year by year, Common Equity stood at $1.7 billion in 2021, then increased by 7.32% to $1.8 billion in 2022, then rose by 7.47% to $2.0 billion in 2023, then rose by 5.85% to $2.1 billion in 2024, then dropped by 3.25% to $2.0 billion in 2025.
  • Business Quant data shows Common Equity for TECH at $2.0 billion in Q4 2025, $2.0 billion in Q3 2025, and $1.9 billion in Q2 2025.